Guangdong Marubi Biotechnology Balance Sheet Health
Financial Health criteria checks 5/6
Guangdong Marubi Biotechnology has a total shareholder equity of CN¥3.3B and total debt of CN¥256.4M, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are CN¥4.1B and CN¥730.4M respectively. Guangdong Marubi Biotechnology's EBIT is CN¥189.2M making its interest coverage ratio -5.3. It has cash and short-term investments of CN¥1.2B.
Key information
7.7%
Debt to equity ratio
CN¥256.40m
Debt
| Interest coverage ratio | -5.3x |
| Cash | CN¥1.24b |
| Equity | CN¥3.32b |
| Total liabilities | CN¥730.35m |
| Total assets | CN¥4.05b |
Recent financial health updates
No updates
Recent updates
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Financial Position Analysis
Short Term Liabilities: 603983's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥711.3M).
Long Term Liabilities: 603983's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥19.1M).
Debt to Equity History and Analysis
Debt Level: 603983 has more cash than its total debt.
Reducing Debt: 603983's debt to equity ratio has increased from 0% to 7.7% over the past 5 years.
Debt Coverage: 603983's debt is well covered by operating cash flow (69.6%).
Interest Coverage: 603983 earns more interest than it pays, so coverage of interest payments is not a concern.